Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL
Clinical trial NCT02682641 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02682641
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-18
- Primary completion
- 2019-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.